“Indeed, we and others have demonstrated that: i) antagonists of either …–aldosterone or β-adrenergic systems enhance NO-dependent pathways; ii) although carvedilol and amlodipine belong to different drug …, both of them can increase cardiac adenosine levels; iii) increased adenosine levels by dipyridamole … associated with the improvement of CHF.”